Theranostics 2011; 1:3-17. doi:10.7150/thno/v01p0003 This volume

Research Paper

Note: A reader recently brought concerns to the attention of the Editor of Theranostics related to two of the figures in this article. This matter is currently under investigation and this expression of concern will continue to be associated with the article until the investigation is concluded.

Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer

Ekaterina Y. Lukianova-Hleb1, Alexander O. Oginsky1,2, Adam P. Samaniego1, Derek L. Shenefelt3, Daniel S. Wagner3, Jason H. Hafner4, Mary C. Farach-Carson3, Dmitri O. Lapotko1,3,4

1. Joint American-Belarusian Laboratory for Fundamental and Biomedical Nanophotonics, Rice University, 6100 Main Street, Houston, TX, 77005, USA;
2. Belarusian State University for Informatics and Radioelectronics, 6 Browka Street, Minsk, 220013, Belarus;
3. Department of Biochemistry & Cell Biology, Rice University, 6100 Main Street, Houston, TX, 77251-1892, USA;
4. Department of Physics & Astronomy, Rice University, 6100 Main Street, Houston, TX 77005, USA

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See for full terms and conditions.
Lukianova-Hleb EY, Oginsky AO, Samaniego AP, Shenefelt DL, Wagner DS, Hafner JH, Farach-Carson MC, Lapotko DO. Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer. Theranostics 2011; 1:3-17. doi:10.7150/thno/v01p0003. Available from

File import instruction


Theranostic applications require coupling of diagnosis and therapy, a high degree of specificity and adaptability to delivery methods compatible with clinical practice. The tunable physical and biological effects of selective targeting and activation of plasmonic nanobubbles (PNB) were studied in a heterogeneous biological microenvironment of prostate cancer and stromal cells. All cells were targeted with conjugates of gold nanoparticles (NPs) through an antibody-receptor-endocytosis-nanocluster mechanism that produced NP clusters. The simultaneous pulsed optical activation of intracellular NP clusters at several wavelengths resulted in higher optical contrast and therapeutic selectivity of PNBs compared with those of gold NPs alone. The developed mechanism was termed “rainbow plasmonic nanobubbles.” The cellular effect of rainbow PNBs was tuned in situ in target cells, thus supporting a theranostic algorithm of prostate cancer cell detection and follow-up guided destruction without damage to collateral cells. The specificity and tunability of PNBs is promising for theranostic applications and we discuss a fiber optic platform that will capitalize on these features to bring theranostic tools to the clinic.

Keywords: Plasmonic nanobubble, gold nanoparticle, laser, photothermal, prostate cancer, theranostics.